• Organization
    FDA/CDRH/OSEL, Division of Imaging, Diagnostics, and Software Reliability

  • Reason
    (not set)

  • Interests
    (not set)

  • Biography
    Brandon D. Gallas provides mathematical, statistical, and modeling expertise to the evaluation of medical imaging devices at the FDA. His main areas of research are image quality, computer-aided diagnosis, imaging physics, and the design, execution, and statistical analysis of reader studies ([], Recently, he has been investigating pathologist performance and agreement using whole slide imaging devices and the microscope ( These studies are enabled by an evaluation environment that registers the digital images to the glass slides ( ). Dr. Gallas also participates in the Pathology Innovation Collaborative Community (, a regulatory science initiative to harmonize and standardize digital pathology processes to speed up innovation to patients.